Compare CODX & MGRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CODX | MGRX |
|---|---|---|
| Founded | 2013 | 2021 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.6M | 15.6M |
| IPO Year | 2017 | 2023 |
| Metric | CODX | MGRX |
|---|---|---|
| Price | $0.36 | $1.10 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $2.25 | N/A |
| AVG Volume (30 Days) | 1.7M | ★ 3.9M |
| Earning Date | 11-13-2025 | 11-14-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $507,892.00 | $466,908.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $18.89 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.23 | $0.98 |
| 52 Week High | $1.55 | $6.15 |
| Indicator | CODX | MGRX |
|---|---|---|
| Relative Strength Index (RSI) | 48.59 | 39.67 |
| Support Level | $0.34 | $1.06 |
| Resistance Level | $0.41 | $1.25 |
| Average True Range (ATR) | 0.04 | 0.11 |
| MACD | 0.00 | 0.04 |
| Stochastic Oscillator | 42.96 | 45.41 |
Co-Diagnostics Inc is a molecular diagnostics company. It develops, licenses, and commercializes molecular technologies such as lab systems (MDx device) and manufacture and sell reagents used for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). CDI's low-cost system uses its tests to diagnose tuberculosis, Zika, hepatitis B and C, Malaria, dengue and HIV.The Company's technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious diseases.
Mangoceuticals Inc focuses on developing, marketing, and selling a variety of men's wellness products and services through a telemedicine platform. The company's platform provides access for customers to a licensed pharmacy for online fulfillment and distribution of certain medications that may be prescribed as part of telehealth consultations, including Mango ED products.